Cytogenetic Biodosimetry Laboratory Laboratory is a critical resource in the event of mass casualties involving radiological or nuclear materials

The REAC/TS CBL is the only CLIA-certified actively operational lab in the United States performing retrospective cytogenetic biodosimetry dose assessment.

By operating a cytogenetic biodosimetry laboratory (CBL), the Oak Ridge Institute for Science and Education is helping the U.S. Department of Energy close a critical gap in our nation’s ability to respond to a radiological or nuclear incident. The use of radiation for medical, industrial, research and other applications raises the risk of accidental human exposure. In addition, the growing threat of radiological/nuclear terrorism poses a serious risk to human health and welfare.

What is cytogenetic biodosimetry?

Cytogenetic biodosimetry is a proven technique that can be used to help calculate the absorbed radiation dose in exposed individuals. Information on individualized radiation dose assists in better treatment decisions and better management of valuable emergency response resources.

The CBL at the Radiation Emergency Assistance Center/Training Site (REAC/TS) performs the individualized radiation dose assessment using the “gold standard” dicentric chromosome assay. Currently, the CBL is the only federally funded facility certified by Clinical Laboratory Improvement Amendments (CLIA) to provide absorbed radiation dose in exposed humans. The CBL has been successful in obtaining the ISO 9001 certification for quality and performance each year. The REAC/TS CBL is a collaborating partner for the World Health Organization (WHO) and is one of the actively participating laboratories in annually conducted international exercises that are designed to evaluate the competency and proficiency of radiation dose assessment.

Recently, the CBL has initiated the development of high throughput platforms for many of the cytogenetic applications and novel biomarkers, which will enable rapid dose assessment of individuals in case of mass casualty incidents. The CBL is fully equipped to perform state-of-the-art techniques, such as multicolor fluorescence in situ hybridization (FISH), which are useful for monitoring and predicting the long-term effects of ionizing radiation in exposed individuals (see example below).

How does cytogenetic biodosimetry work?

When energy generated by ionizing forms of radiation is transferred to human cells and tissues, damage is induced in the chromosomal DNA depending on the amount of absorbed radiation energy.

Several types of chromosomal aberrations can be induced by ionizing radiation exposure. One type of aberration is known as a dicentric chromosome, which is formed by a fusion of two chromosomes with centromeres after DNA breakage. The dicentric chromosome formation has been shown to be highly specific for radiation exposure. Since the yield of dicentric chromosomes depends on radiation dose, absorbed whole body dose can be estimated from the frequency of dicentric chromosomes fitted to a standard calibration curve generated with known doses of radiation.

The dicentric chromosome assay enables ORISE’s cytogenetics researchers to quantify chromosomal DNA damage and provide an accurate dose estimate for patients who may require immediate and specialized medical care. This valuable tool allows decision makers and public health officials to assess the magnitude of exposure for better allocation of available medical resources in the aftermath of mass casualty incidents.